The Pharma Data
AUGUST 20, 2020
It has since expanded nationwide, threatening an important market for many Big Pharma players. . At the time, Wolfe Research analyst Tim Anderson wondered whether the decline was the “canary in the coalmine” for the rest of the industry, which has been relying on the lucrative China market for revenue growth.
XTalks
APRIL 13, 2021
New data from the Plant Based Foods Association (PBFA) and The Good Food Institute (GFI) shows that the retail sales of plant-based foods in the US grew by 27 percent in 2020, bringing its total market value to $7 billion. of the $7 billion market. Plant-Based Milk Sales. Plant-Based Meat Sales. billion in sales in 2020.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Roots Analysis
JANUARY 23, 2024
The peptide therapeutics market has undergone substantial evolution since the inception of insulin. Presently, over 80 peptide-based drugs are available in the market for myriad of disorders and diseases. Presently, over 80 peptide-based drugs are available in the market for myriad of disorders and diseases.
ACRP blog
NOVEMBER 8, 2023
“With retail pharmacies entering the clinical trial space, investigative sites are left with little information around how this move will affect them or their patients,” says Emily Botto, Senior Research Analyst at the Tufts Center for the Study of Drug Development (CSDD) and a scheduled presenter at the ACRP 2024 conference in Anaheim, Calif.
ACRP blog
NOVEMBER 8, 2023
“With retail pharmacies entering the clinical trial space, investigative sites are left with little information around how this move will affect them or their patients,” says Emily Botto, Senior Research Analyst at the Tufts Center for the Study of Drug Development (CSDD) and a scheduled presenter at the ACRP 2024 conference in Anaheim, Calif.
Roots Analysis
OCTOBER 12, 2023
Strategic Relationships: This parameter represents the strategic alliances, partners, or a burgeoning customer base in order to evaluate the marketing risks of a start-up. As a senior analyst at Roots Analysis, Gaurav has assisted several clients across multiple industry verticals within the healthcare domain.
The Pharma Data
DECEMBER 31, 2020
Prior to that, Zhang was an equity research analyst at UBS in New York, where he covered the Major and Specialty Pharmaceutical Sector. a publicly-listed company investing in blockchain technology solutions for capital markets and other sectors that can benefit from tokenization. He is currently the CEO of BlockchainK2 Corp.,
Expert insights. Personalized for you.
52 
Let's personalize your content